인쇄하기
취소
|
While the Hanmi Pharm’s delayed report about patient side effects has aroused various doubts, a suggestion was made if the National Pension Service should file a damage claim for estimated losses of KRW 150 billion on investment into Hanmi Pharm.
On the 10th, Assemblyperson Kwang-Soo Kim from the People’s Party, who made questions at the National Inspection for the National Pension Service(NPS...